Abstract

BackgroundPharmacovigilance is a key medicine safety aspect, which is an important principle of patient care and a critical component of quality management. Improving it requires a comprehensive approach, a task...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR
Ana Quinteros ... Pablo Finucci Curi
Clinical Rheumatology | VOL. 38
Ana Quinteros, et. al.Ana Quinteros ... Pablo Finucci Curi
17 Apr 2019
Medication Safety
-
Journal of Pharmacy Practice and Research | VOL. 46
--
01 Jun 2016
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody.
Aurelie Verles ... Edwige Chokoté
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | VOL. 20
Aurelie Verles, et. al.Aurelie Verles ... Edwige Chokoté
06 Dec 2019
Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy
James D Lewis ... Kevin Winthrop
Annals of the Rheumatic Diseases | VOL. 74
James D Lewis, et. al.James D Lewis ... Kevin Winthrop
07 Mar 2014
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
Myrto Kostopoulou ... Antonis Fanouriakis
Annals of the Rheumatic Diseases | VOL. -
Myrto Kostopoulou, et. al.Myrto Kostopoulou ... Antonis Fanouriakis
22 May 2024
View more papers